INTRODUCTION
Junctional adhesion molecule-A (JAM-A) is a tight junctionassociated protein that is responsible for several functions in epithelial and endothelial cells. Recent studies from our lab and others show that JAM-A is required for the maintenance of intestinal epithelial cell (IEC) homeostasis and barrier function (Laukoetter et al, 2007; Vetrano et al, 2008) . JAM-A contains two extracellular immunoglobulin loops, a transmembrane domain and a short cytoplasmic tail. The distal extracellular immunoglobulin loop mediates homodimerization between JAM-A proteins, which form intercellular contacts (Kostrewa et al, 2001; Prota et al, 2003; Severson et al, 2008) . The cytoplasmic tail of JAM-A interacts with several intracellular scaffolding molecules including ZO-1, AF6, Par3 and PDZ-GEF2 (reviewed by ). Indeed, JAM-A is believed to stimulate outside-in signalling through dimerization-dependent scaffold protein recruitment ). However, the signalling events through which JAM-A mediates many of its biological functions are unclear.
Akt/protein kinase B is a serine/threonine-specific kinase that is involved in several pathways regulating cell growth, differentiation and proliferation (Dummler & Hemmings, 2007) . Aberrant activation of Akt is often observed in human cancers, and a direct role for Akt signalling in the regulation of cell proliferation has been shown in several transgenic mouse models (Luo et al, 2003; Dillon et al, 2007) . In the intestine, b-catenin not only functions as a downstream effector of canonical Wnt signalling to promote crypt stem-cell proliferation (Li & Clevers, 2010) , but also can be transactivated by Akt-mediated phosphorylation at Ser 552 (Fang et al, 2007) .
In this study, we investigate the role of JAM-A in IEC proliferation and epithelial homeostasis. We observe that loss of JAM-A expression enhances IEC proliferation in vivo and in vitro, which requires JAM-A dimerization. Investigations into the signalling mechanisms involved reveal that increased proliferation requires phosphatidylinositol 3-kinase (PI3K) and phosphatase and tensin homologue (PTEN)-dependent, Akt-mediated b-catenin transcriptional activation, as inhibition of Akt is sufficient to rescue epithelial hyperproliferation. In light of these results, we propose that JAM-A contributes to intestinal epithelial homeostasis by regulating b-catenin signalling.
RESULTS AND DISCUSSION
JAM-A-deficient mice (JAM-A À/À ) show enhanced colonic crypt Ki67 staining (Laukoetter et al, 2007) . Therefore, we investigated the role of JAM-A in cell proliferation by using 5-bromo-2-deoxyuridine (BrdU) incorporation in wild-type and JAM-A À/À mice. Mice were analysed 4 h after injection and a significant increase in proliferation was found in colonic crypts of JAM-A À/À mice (Fig 1A,B) . Our observations indicate that loss of JAM-A results in either an increase in the rate of colonic stem-cell division, combined with enhanced progenitor cell migration, or in increased proliferation within transient amplifying cell populations. To distinguish between these possibilities, we performed BrdU pulse-chase experiments (Fig 1C,D) . Increased cell migration is shown by the height of BrdU-positive cells along the crypt-to-surface axis, which is increased in JAM-A À/À mice at all time points. Increased BrdU incorporation was seen at 1 h, at which time cells are seen at higher positions along the cryptto-surface axis. At this time, cell migration has a small role in determining cell position along the crypt-to-surface axis. Therefore, the increased cell proliferation in JAM-A À/À mice seen after 1 h BrdU incorporation is due to increased proliferation in the transient amplifying zone. Crypt length was unchanged (data not shown), probably because of a compensatory increase in IEC apoptosis at the luminal interface (supplementary Fig S1A online ; Vetrano et al, 2008) . Taken together, these results show that JAM-A is a negative regulator of IEC proliferation and migration in vivo.
JAM-A À/À mice have decreased IEC barrier function and increased mucosal inflammation (Laukoetter et al, 2007; Vetrano et al, 2008) . To exclude the possibility that increased proliferation in vivo is due to mitogenic paracrine signalling in response to immune activation, we conducted complementary experiments with model human IECs, SKCO15. As shown in Fig 2A, JAM-A small interfering RNA (siRNA) strongly downregulated protein expression 48 h after transfection. Consistent with in vivo data, JAM-A downregulation was sufficient to induce IEC proliferation, as indicated by increased tetrazolium salt metabolism (MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay; Fig 2B) and increased BrdU incorporation (Fig 2C) . The above findings indicate that JAM-A directly regulates IEC proliferation. JAM-A intercellular signalling requires protein homodimerization . To investigate whether this is required to suppress cell proliferation, we assessed HEK 293T cells stably expressing full-length or dimerization-defective mutant JAM-A lacking the distal immunoglobulin loop (Fig 2D,E) . Only full-length JAM-A reduced cell growth. These findings were confirmed by rescue experiments in SKCO15 cells, in which expression of full-length, but not dimerization-defective JAM-A, JAM-A restricts epithelial cell proliferation P. Nava et al attenuated the increase in cell proliferation after JAM-A depletion (supplementary Fig S1B- E online) . These data show that JAM-A dimerization is required to suppress epithelial cell proliferation.
To identify signalling pathways that control IEC proliferation downstream of JAM-A, we analysed the activity of Akt, a known regulator of epithelial homeostasis (Itoh et al, 2002; Cao et al, 2006) . Depletion of JAM-A in SKCO15 cells using different siRNA constructs resulted in a significant increase in Akt activity, as indicated by phosphorylation of Thr 308 (Fig 3A,B) . Similarly, increased Akt activity was observed in mucosal lysates of JAM-A À/À mice, compared with controls ( Fig 3C) . Previous studies have shown that Akt can enhance b-catenin signalling in two ways: by phosphorylation of b-catenin at Ser 552, thereby promoting its nuclear translocation and association with T-cell factor (TCF)/lymphoid enhancing factor family transcription factors (Behrens et al, 1996; Daniels & Weis, 2005; Fang et al, 2007) , and by inhibition of GSK-3b, a potent negative regulator of b-catenin protein stability (Cross et al, 1995) . Analysis of mucosal lysates showed a consistent increase in b-catenin pSer 552 in JAM-A À/À mice (Fig 3D) , and immunolocalization showed a significantly increased number of proliferating IECs with nuclear pSer 552 in these animals (Fig 3E,F) . By contrast, we observed no difference in mucosal GSK-3b activity, and total b-catenin expression was variable between animals ( Fig 3D, data not  shown) . Thus, although we cannot exclude a possible contribution of increased b-catenin protein levels to increased IEC proliferation in these mice, our findings indicate that altered activity, rather than the stability of b-catenin, accounts for the findings in this study. Taken together, these results show that JAM-A regulates epithelial cell proliferation by inhibiting Akt/b-catenin signalling.
To corroborate these observations in vitro, we generated an SKCO15 cell line stably expressing a doxycyclin-inducible JAM-A short-hairpin RNA. In agreement with the data from JAM-A À/À mice, depletion of JAM-A by doxycyclin treatment increased the JAM-A restricts epithelial cell proliferation P. Nava et al phosphorylation of Akt and b-catenin (Fig 4A) . Loss of JAM-A resulted in nuclear translocation of b-catenin pSer 552, in agreement with previous studies (supplementary Fig S2A online) . In addition, we used a luciferase-based b-catenin/TCF transcriptional activity assay (TOPFLASH/FOPFLASH) to determine b-cateninmediated gene transcription. As shown in Fig 4B, loss of JAM-A on doxycyclin exposure was associated with a significant increase in b-catenin transcriptional activity, which was not the case in control cells treated with doxycyclin (supplementary Fig S2B online) , and which was additionally confirmed by transient depletion using siRNA (data not shown). To further support our conclusions, we cross-bred JAM-A À/À mice with previously described b-catenin reporter mice that express the lacZ gene under the control of b-catenin/TCF responsive elements (BAT-gal; Maretto et al, 2003) . The BAT-gal transgene, as well as JAM-A deletion, was confirmed by PCR, as shown in Fig 4C. In agreement with the in vitro data, strong b-galactosidase activity was observed in the distal colon of JAM-A À/À mice (Fig 4D) . To further localize reporter activity within the intestine, we isolated and analysed colonic crypts. Similar to previous reports, BAT-gal colonic crypts showed minimal lacZ signal in the base of the crypt ( Fig 4D, right panel ; Maretto et al, 2003) . However, a striking increase in lacZ staining was observed in JAM-A À/À /BAT-gal crypts in both transient amplifying cells and crypt cells (Fig 4D) . We thus conclude that JAM-A regulates b-catenin/TCF-mediated gene transcription in vivo.
The above results indicate that Akt/b-catenin is the key regulator of IEC proliferation downstream of JAM-A. To test this hypothesis, Akt activity was inhibited by using Triciribine in cells treated with scramble or JAM-A siRNA, which efficiently reduced phosphorylation of Akt and b-catenin (Fig 4E) . Under these conditions, b-catenin transcriptional activity was reduced after Triciribine treatment, as indicated by TOPFLASH assay (Fig 4F) . Furthermore, we observed a significant reduction in SKCO15 proliferation after Triciribine treatment (data not shown). As Triciribine reduced total Akt expression, we confirmed our findings by using a peptide inhibitor of Akt, Akt-in and Akt siRNA. Importantly, both treatments yielded results similar to those observed with Triciribine, and Akt-in did not change Akt expression (supplementary Fig S3A,B online) . Treatment of controls with Triciribine also suppressed Akt downstream effectors, which is consistent with the presence of functioning Akt-dependent pathways in control cells that are potentiated after JAM-A suppression. Taken together, these findings suggest that Akt is the main effector of JAM-A-mediated mitogenic signalling.
To corroborate our in vitro results, we analysed the effect of Akt inhibition on IEC proliferation in JAM-A À/À mice. Wild-type or JAM-A-knockout mice were treated with the Akt inhibitor Triciribine, injected with BrdU and analysed 4 h post-injection (Fig 4G) . JAM-A restricts epithelial cell proliferation P. Nava et al mice, which coincided with a decrease in Akt Thr 308 phosphorylation (supplementary Fig S3C online) . Indeed, inhibition of Akt activity is sufficient to attenuate the increased cell proliferation seen in JAM-A À/À animals.
To explain the way in which JAM-A engages with Akt to regulate b-catenin transcriptional activity, we examined the levels of Akt activator phosphatidylinositol (3,4,5)-trisphosphate (PIP 3 ) in our experimental system. Depletion of JAM-A in SKCO15 cells . We also found that depletion of PTEN increased Akt phosphorylation and b-catenin transcriptional activity, which did not rescue the effect of Akt inhibition, confirming that PTEN functions upstream of Akt (supplementary Fig S5C,D online) . Finally, additional studies of alternative pathways linking JAM-A to Akt showed that integrin-linked kinase and Rap1 were not involved in Akt activation after loss of JAM-A (data not shown).
It is important to note that this observation does not exclude the fact that other signalling pathways that are not investigated here affect epithelial homeostasis following loss of JAM-A. Similarly, it is possible that b-catenin transcriptional activity is additionally regulated by other proteins such as protein kinase A (Taurin et al, 2006) . Nevertheless, the results presented here indicate that JAM-A regulates Akt activity by controlling PIP 3 levels in a PI3K-and PTEN-dependent manner. As schematically summarized in Fig 5, we thus conclude that homodimerization of JAM-A in IECs decreases cell proliferation by dampening Akt activity and b-catenin transcriptional activation.
METHODS
Animal experiments. JAM-A À/À mice were a gift from T. Sato, Cornell University (New York, NY, USA) and C57BL/6 (wild-type) mice were obtained from The Jackson Laboratory. JAM-A À/À mice were genotyped as described previously (Cera et al, 2004) . lacZ integration in BAT-gal reporter mice (The Jackson Laboratory) was confirmed by PCR, as reported previously (Maretto et al, 2003) . Akt was inhibited by daily intraperitoneal injection of 1 mg/kg body weight Triciribine for 7 days, with dimethylsulphoxide as control. All procedures using animals were reviewed and approved by the Emory University Institutional Animal Care and Use Committee, according to the criteria of the National Institutes of Health. Cell proliferation assays. BrdU (Sigma-Aldrich) was administered by intraperitoneal injection of 50 mg/kg body weight. BrdU was detected after ethanol and glycine fixation of intestinal frozen sections. Specimens were digested with 0.05% trypsin and antigen retrieved by denaturation with 4 M HCl. Slides were incubated with fluorophore-labelled BrdU antibody (Roche Pharmaceuticals). Proliferation in vitro was assessed by BrdU or MTT assay (Roche Pharmaceuticals). For BrdU scoring, longitudinal sections were selected such that both crypt base and luminal surface cells were visible. Apoptosis in vivo was determined by detecting cleaved Caspase-3 (R&D Systems). (2) inactivation of PTEN. Consequently, in the absence of JAM-A, Akt is recruited to the membrane and phosphorylated at Thr 308 probably by its activating kinase PDK1. Active Akt phosphorylates b-catenin at Ser 552, which promotes its nuclear translocation and enhances its activity as a transcription cofactor for TCF. Thus, we propose that JAM-A (dimerization) restricts epithelial-cell proliferation by negatively regulating Akt/b-catenin signalling. JAM-A, junctional adhesion molecule-A; PDK1, 3-phosphoinositide-dependent protein kinase 1; PIP 3 , phosphatidylinositol (3,4,5)-trisphosphate; PI3K, phosphatidylinositol 3-kinase; PTEN, phosphatase and tensin homologue; TCF, T-cell factor.
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